215 related articles for article (PubMed ID: 20051100)
1. IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.
Rajski M; Zanetti-Dällenbach R; Vogel B; Herrmann R; Rochlitz C; Buess M
BMC Med; 2010 Jan; 8():1. PubMed ID: 20051100
[TBL] [Abstract][Full Text] [Related]
2. Basic and clinical significance of IGF-I-induced signatures in cancer.
Werner H; Bruchim I
BMC Med; 2010 Jan; 8():2. PubMed ID: 20051101
[TBL] [Abstract][Full Text] [Related]
3. BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas.
Rajski M; Saaf A; Buess M
BMC Med Genomics; 2015 Apr; 8():16. PubMed ID: 25924783
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
Mu L; Tuck D; Katsaros D; Lu L; Schulz V; Perincheri S; Menato G; Scarampi L; Harris L; Yu H
Breast Cancer Res Treat; 2012 May; 133(1):321-31. PubMed ID: 22297468
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling.
Frings O; Augsten M; Tobin NP; Carlson J; Paulsson J; Pena C; Olsson E; Veerla S; Bergh J; Ostman A; Sonnhammer EL
Am J Pathol; 2013 Jun; 182(6):2037-47. PubMed ID: 23583284
[TBL] [Abstract][Full Text] [Related]
6. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.
Creighton CJ; Casa A; Lazard Z; Huang S; Tsimelzon A; Hilsenbeck SG; Osborne CK; Lee AV
J Clin Oncol; 2008 Sep; 26(25):4078-85. PubMed ID: 18757322
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.
Leithner K; Wohlkoenig C; Stacher E; Lindenmann J; Hofmann NA; Gallé B; Guelly C; Quehenberger F; Stiegler P; Smolle-Jüttner FM; Philipsen S; Popper HH; Hrzenjak A; Olschewski A; Olschewski H
BMC Cancer; 2014 Jan; 14():40. PubMed ID: 24460801
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.
Guo X; Zhu SX; Brunner AL; van de Rijn M; West RB
Breast Cancer Res; 2013 Dec; 15(6):R117. PubMed ID: 24342436
[TBL] [Abstract][Full Text] [Related]
10. Stromal responses among common carcinomas correlated with clinicopathologic features.
Chen JL; Espinosa I; Lin AY; Liao OY; van de Rijn M; West RB
Clin Cancer Res; 2013 Sep; 19(18):5127-35. PubMed ID: 23804424
[TBL] [Abstract][Full Text] [Related]
11. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.
Singer C; Rasmussen A; Smith HS; Lippman ME; Lynch HT; Cullen KJ
Cancer Res; 1995 Jun; 55(11):2448-54. PubMed ID: 7757999
[TBL] [Abstract][Full Text] [Related]
12. Stromal LRP1 in lung adenocarcinoma predicts clinical outcome.
Meng H; Chen G; Zhang X; Wang Z; Thomas DG; Giordano TJ; Beer DG; Wang MM
Clin Cancer Res; 2011 Apr; 17(8):2426-33. PubMed ID: 21325077
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.
Planche A; Bacac M; Provero P; Fusco C; Delorenzi M; Stehle JC; Stamenkovic I
PLoS One; 2011; 6(5):e18640. PubMed ID: 21611158
[TBL] [Abstract][Full Text] [Related]
14. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
16. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
Rudisch A; Dewhurst MR; Horga LG; Kramer N; Harrer N; Dong M; van der Kuip H; Wernitznig A; Bernthaler A; Dolznig H; Sommergruber W
PLoS One; 2015; 10(4):e0124283. PubMed ID: 25919140
[TBL] [Abstract][Full Text] [Related]
17. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA
Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821
[TBL] [Abstract][Full Text] [Related]
18. Variations in stromal signatures in breast and colorectal cancer metastases.
Webster JA; Beck AH; Sharma M; Espinosa I; Weigelt B; Schreuder M; Montgomery KD; Jensen KC; van de Rijn M; West R
J Pathol; 2010 Oct; 222(2):158-65. PubMed ID: 20593409
[TBL] [Abstract][Full Text] [Related]
19. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
20. Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.
Sonnenberg M; van der Kuip H; Haubeis S; Fritz P; Schroth W; Friedel G; Simon W; Mürdter TE; Aulitzky WE
BMC Cancer; 2008 Dec; 8():364. PubMed ID: 19077243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
